{"id":"https://openalex.org/W4387728871","doi":"https://doi.org/10.1001/jamanetworkopen.2023.36914","title":"Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees","display_name":"Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees","alternate_titles":[],"publication_year":2023,"publication_date":"2023-10-18","ids":{"openalex":"https://openalex.org/W4387728871","doi":"https://doi.org/10.1001/jamanetworkopen.2023.36914","pmid":"https://pubmed.ncbi.nlm.nih.gov/37851446","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10585416"},"language":"en","primary_location":{"id":"doi:10.1001/jamanetworkopen.2023.36914","doi":"https://doi.org/10.1001/jamanetworkopen.2023.36914","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamanetworkopen.2023.36914","pdf_url":"https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2810828/hammerslag_2023_oi_231073_1697031989.25419.pdf","source":{"id":"https://openalex.org/S4210217848","display_name":"JAMA Network Open","issn_l":"2574-3805","issn":["2574-3805"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Network Open","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4387728871"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2810828/hammerslag_2023_oi_231073_1697031989.25419.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049356887","display_name":"Lindsey R. Hammerslag","orcid":"https://orcid.org/0000-0003-0750-6656","observed_orcids":["https://orcid.org/0000-0003-0750-6656"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lindsey R. Hammerslag","raw_affiliation_strings":["Institute for Biomedical Informatics, University of Kentucky College of Medicine, Lexington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Biomedical Informatics, University of Kentucky College of Medicine, Lexington","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006147059","display_name":"Aimee Mack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aimee Mack","raw_affiliation_strings":["Division of Health Sciences, The Ohio State University Wexner Medical Center, Columbus"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Health Sciences, The Ohio State University Wexner Medical Center, Columbus","institution_ids":["https://openalex.org/I2802841970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109487526","display_name":"Redonna K. Chandler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Redonna K. Chandler","raw_affiliation_strings":["National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086658619","display_name":"Laura C. Fanucchi","orcid":"https://orcid.org/0000-0003-0582-2399","observed_orcids":["https://orcid.org/0000-0003-0582-2399"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura C. Fanucchi","raw_affiliation_strings":["Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, Lexington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, Lexington","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029718424","display_name":"Daniel J. Feaster","orcid":"https://orcid.org/0000-0002-6172-7460","observed_orcids":["https://orcid.org/0000-0002-6172-7460"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. Feaster","raw_affiliation_strings":["Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041921767","display_name":"Marc R. Larochelle","orcid":"https://orcid.org/0000-0001-7344-1200","observed_orcids":["https://orcid.org/0000-0001-7344-1200"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc R. LaRochelle","raw_affiliation_strings":["Clinical Addiction Research & Education Unit, Boston University School of Medicine, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Addiction Research & Education Unit, Boston University School of Medicine, Boston, Massachusetts","institution_ids":["https://openalex.org/I111088046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069600909","display_name":"Michelle R. Lofwall","orcid":"https://orcid.org/0000-0002-5911-0752","observed_orcids":["https://orcid.org/0000-0002-5911-0752"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle R. Lofwall","raw_affiliation_strings":["Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, Lexington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, Lexington","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051799791","display_name":"Michael Nau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Nau","raw_affiliation_strings":["Division of Health Sciences, The Ohio State University Wexner Medical Center, Columbus"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Health Sciences, The Ohio State University Wexner Medical Center, Columbus","institution_ids":["https://openalex.org/I2802841970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032409617","display_name":"Jennifer Villani","orcid":"https://orcid.org/0000-0003-2337-2504","observed_orcids":["https://orcid.org/0000-0003-2337-2504"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Villani","raw_affiliation_strings":["National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021278551","display_name":"SHARON L. WALSH","orcid":"https://orcid.org/0000-0002-9722-5681","observed_orcids":["https://orcid.org/0000-0002-9722-5681"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon L. Walsh","raw_affiliation_strings":["Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, Lexington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, Lexington","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054155667","display_name":"Philip M. Westgate","orcid":"https://orcid.org/0000-0003-2991-268X","observed_orcids":["https://orcid.org/0000-0003-2991-268X"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip M. Westgate","raw_affiliation_strings":["Department of Biostatistics, College of Public Health, University of Kentucky, Lexington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, College of Public Health, University of Kentucky, Lexington","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008931888","display_name":"Svetla S. Slavova","orcid":"https://orcid.org/0000-0002-4541-6574","observed_orcids":["https://orcid.org/0000-0002-4541-6574"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Svetla Slavova","raw_affiliation_strings":["Department of Biostatistics, College of Public Health, University of Kentucky, Lexington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, College of Public Health, University of Kentucky, Lexington","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012614682","display_name":"Jeffery Talbert","orcid":"https://orcid.org/0000-0002-4304-5167","observed_orcids":["https://orcid.org/0000-0002-4304-5167"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffery C. Talbert","raw_affiliation_strings":["Institute for Biomedical Informatics, University of Kentucky College of Medicine, Lexington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Biomedical Informatics, University of Kentucky College of Medicine, Lexington","institution_ids":["https://openalex.org/I143302722"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5049356887"],"corresponding_institution_ids":["https://openalex.org/I143302722"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":13.8782,"has_fulltext":true,"cited_by_count":67,"citation_normalized_percentile":{"value":0.99499193,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"6","issue":"10","first_page":"e2336914","last_page":"e2336914"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10912","display_name":"Telemedicine and Telehealth Implementation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ine","display_name":"INE","score":0.5199999809265137},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.8100000023841858},{"id":"https://openalex.org/keywords/telemedicine","display_name":"telemedicine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/treatment-retention","display_name":"treatment retention","score":0.9010000228881836},{"id":"https://openalex.org/keywords/medicaid-enrollees","display_name":"Medicaid enrollees","score":0.902999997138977},{"id":"https://openalex.org/keywords/covid-19-public-health-emergency","display_name":"COVID-19 emergency","score":0.9589999914169312},{"id":"https://openalex.org/keywords/kentucky","display_name":"Kentucky","score":0.40400001406669617},{"id":"https://openalex.org/keywords/ohio","display_name":"Ohio","score":1.0},{"id":"https://openalex.org/keywords/opioid-use-disorder-treatment-access","display_name":"opioid use disorder treatment access","score":0.4740000069141388}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.9570695757865906},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.883925199508667},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8452118635177612},{"id":"https://openalex.org/C2776534028","wikidata":"https://www.wikidata.org/wiki/Q1141363","display_name":"Medicaid","level":3,"score":0.7963511943817139},{"id":"https://openalex.org/C2779891985","wikidata":"https://www.wikidata.org/wiki/Q46994","display_name":"Telemedicine","level":3,"score":0.5845659971237183},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5312041640281677},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.46513646841049194},{"id":"https://openalex.org/C2779148768","wikidata":"https://www.wikidata.org/wiki/Q17154378","display_name":"Opioid overdose","level":5,"score":0.4624825417995453},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4414488971233368},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4179949462413788},{"id":"https://openalex.org/C2909451232","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opiate Substitution Treatment","level":5,"score":0.41039371490478516},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.36659950017929077},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.35603243112564087},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3385999798774719},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22254517674446106},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.08389881253242493},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000083682","descriptor_name":"Opiate Overdose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008484","descriptor_name":"Medicaid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017216","descriptor_name":"Telemedicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058850","descriptor_name":"Opiate Substitution Treatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058873","descriptor_name":"Pandemics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1001/jamanetworkopen.2023.36914","doi":"https://doi.org/10.1001/jamanetworkopen.2023.36914","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamanetworkopen.2023.36914","pdf_url":"https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2810828/hammerslag_2023_oi_231073_1697031989.25419.pdf","source":{"id":"https://openalex.org/S4210217848","display_name":"JAMA Network Open","issn_l":"2574-3805","issn":["2574-3805"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Network Open","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10585416","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10585416","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Netw Open","raw_type":"Text"},{"id":"pmid:37851446","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37851446","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA network open","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1001/jamanetworkopen.2023.36914","doi":"https://doi.org/10.1001/jamanetworkopen.2023.36914","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamanetworkopen.2023.36914","pdf_url":"https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2810828/hammerslag_2023_oi_231073_1697031989.25419.pdf","source":{"id":"https://openalex.org/S4210217848","display_name":"JAMA Network Open","issn_l":"2574-3805","issn":["2574-3805"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Network Open","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G1009764801","display_name":"CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State","funder_award_id":"UM1DA049415","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G1635024425","display_name":null,"funder_award_id":"NCT04111939","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1674180083","display_name":"Optimizing HEALing in Ohio Communities (OHiO)","funder_award_id":"UM1DA049417","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G1794071380","display_name":"HEALing Communities Study Data Coordinating Center","funder_award_id":"UM1DA049394","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G3423472107","display_name":"Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term)","funder_award_id":"UM1DA049406","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G4067867360","display_name":null,"funder_award_id":"NCT04111939","funder_id":"https://openalex.org/F4320332164","funder_display_name":"Substance Abuse and Mental Health Services Administration"},{"id":"https://openalex.org/G7781449908","display_name":"MassHEAL - Reducing overdose deaths by 40% (2019-2023)","funder_award_id":"UM1DA049412","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000906086","display_name":"Training Program on HIV and Substance Use in the Criminal Justice System","funder_award_id":"T32DA037801","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320312424","display_name":"Vanda Pharmaceuticals","ror":"https://ror.org/0394qmm90"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332164","display_name":"Substance Abuse and Mental Health Services Administration","ror":"https://ror.org/03t3qg659"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387728871.pdf","grobid_xml":"https://content.openalex.org/works/W4387728871.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W2307997912","https://openalex.org/W2599076725","https://openalex.org/W2616473434","https://openalex.org/W2902808758","https://openalex.org/W3036510594","https://openalex.org/W3039751098","https://openalex.org/W3048094738","https://openalex.org/W3048369075","https://openalex.org/W3081101017","https://openalex.org/W3087245579","https://openalex.org/W3092427022","https://openalex.org/W3099105066","https://openalex.org/W3101969700","https://openalex.org/W3103545929","https://openalex.org/W3130824237","https://openalex.org/W3156324838","https://openalex.org/W3173815853","https://openalex.org/W3179112797","https://openalex.org/W3180774728","https://openalex.org/W3196562351","https://openalex.org/W3198649527","https://openalex.org/W3214882210","https://openalex.org/W4200116480","https://openalex.org/W4206728533","https://openalex.org/W4238860032","https://openalex.org/W4281680133","https://openalex.org/W4288077275","https://openalex.org/W4293801899","https://openalex.org/W4293802350","https://openalex.org/W4304695145","https://openalex.org/W4380870962"],"related_works":["https://openalex.org/W3201125609","https://openalex.org/W4387858972","https://openalex.org/W7164997543","https://openalex.org/W3128275005","https://openalex.org/W3217353719","https://openalex.org/W4386456460","https://openalex.org/W3168477510","https://openalex.org/W4304695145","https://openalex.org/W4403996628","https://openalex.org/W4206306026"],"abstract_inverted_index":{"Importance:":[0],"Early":[1],"COVID-19":[2,46,378],"mitigation":[3],"strategies":[4],"placed":[5],"an":[6],"additional":[7],"burden":[8],"on":[9],"individuals":[10,86,223,239],"seeking":[11],"care":[12],"for":[13,85,203,321,364,395],"opioid":[14],"use":[15,392],"disorder":[16],"(OUD).":[17],"Telemedicine":[18,271,327],"provided":[19],"a":[20,166,176,192,317],"way":[21],"to":[22,81,89,383],"initiate":[23],"and":[24,50,57,63,74,94,99,131,141,155,208,236,260,268,324,353],"maintain":[25],"transmucosal":[26,36,123,180],"buprenorphine":[27,37,124,181,196,204,254,265,272,296,363,367],"treatment":[28,39,55,126,152,183,374,396],"of":[29,54,116,121,148,201,279,292,359,393,397],"OUD.":[30,398],"Objective:":[31],"To":[32],"examine":[33],"associations":[34],"between":[35],"OUD":[38,125,182],"modality":[40,120],"(telemedicine":[41],"vs":[42],"traditional)":[43],"during":[44,107,376],"the":[45,51,119,122,277,377,384,391],"public":[47],"health":[48,52],"emergency":[49],"outcomes":[53,147,162,388],"retention":[56,150,294,372],"opioid-related":[58,156,333],"nonfatal":[59,157,334],"overdose.":[60],"Design,":[61],"Setting,":[62],"Participants:":[64],"This":[65,218],"retrospective":[66],"cohort":[67,357],"study":[68,178,219,358],"was":[69,118,170,185,205,287,329,369],"conducted":[70],"using":[71],"Medicaid":[72,360],"claims":[73],"enrollment":[75],"data":[76,105],"from":[77,92],"November":[78],"1,":[79],"2019,":[80],"December":[82],"31,":[83],"2020,":[84,256],"aged":[87],"18":[88,258],"64":[90],"years":[91],"Kentucky":[93,225,267],"Ohio.":[95],"Data":[96],"were":[97,134,144],"collected":[98],"analyzed":[100],"in":[101,109,136,151,195,215,224,240,255,266,297,316,373],"June":[102],"2022,":[103],"with":[104,257,282,289,295,332,371,390],"updated":[106],"revision":[108],"August":[110],"2023.":[111],"Exposures:":[112],"The":[113,172],"primary":[114],"exposure":[115],"interest":[117],"initiation.":[127,160],"Relevant":[128],"patient":[129,322],"demographic":[130,323],"comorbidity":[132,325],"characteristics":[133],"included":[135,220],"regression":[137,318],"models.":[138],"Main":[139],"Outcomes":[140],"Measures:":[142],"There":[143],"2":[145],"main":[146,173],"interest:":[149],"after":[153,159,164,189],"initiation":[154,184,188,286,328,368],"overdose":[158,335],"For":[161],"measured":[163],"initiation,":[165,284],"90-day":[167,293],"follow-up":[168],"period":[169],"used.":[171],"analysis":[174,319],"used":[175],"new-user":[177],"design;":[179],"defined":[186],"as":[187],"more":[190],"than":[191],"60-day":[193],"gap":[194],"treatment.":[197],"In":[198,355],"addition,":[199],"uptake":[200],"telemedicine":[202,285,366,394],"examined,":[206],"overall":[207],"within":[209],"patients":[210],"initiating":[211,264],"treatment,":[212],"across":[213],"quarters":[214],"2020.":[216,280],"Results:":[217],"41":[221],"266":[222],"(21":[226],"269":[227],"women":[228,244],"[51.5%];":[229],"mean":[230,246],"[SD]":[231,247],"age,":[232,248],"37.9":[233],"[9.0]":[234],"years)":[235,251],"50":[237],"648":[238],"Ohio":[241],"(26":[242],"425":[243],"[52.2%];":[245],"37.1":[249],"[9.3]":[250],"who":[252],"received":[253],"250":[259],"24":[261],"741":[262],"people":[263],"Ohio,":[269],"respectively.":[270],"initiations":[273],"increased":[274],"sharply":[275],"at":[276],"beginning":[278],"Compared":[281],"nontelemedicine":[283],"associated":[288,331,370,389],"better":[290],"odds":[291,302,310,338,346],"both":[298],"states":[299],"(Kentucky:":[300,336],"adjusted":[301,309,337,345],"ratio,":[303,311,339,347],"1.13":[304],"[95%":[305,313,341,349],"CI,":[306,314,342,350],"1.01-1.27];":[307],"Ohio:":[308,344],"1.19":[312],"1.06-1.32])":[315],"adjusting":[320],"characteristics.":[326],"not":[330],"0.89":[340],"0.56-1.40];":[343],"1.08":[348],"0.83-1.41]).":[351],"Conclusions":[352],"Relevance:":[354],"this":[356],"enrollees":[361],"receiving":[362],"OUD,":[365],"early":[375],"pandemic.":[379],"These":[380],"findings":[381],"add":[382],"literature":[385],"demonstrating":[386],"positive":[387]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4387728871","counts_by_year":[{"year":2026,"cited_by_count":23},{"year":2025,"cited_by_count":20},{"year":2024,"cited_by_count":22},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2023-10-19T00:00:00"}
